India stands 3rd globally for the highest number of HIV cases with 2.4 million patients living with HIV. Experts strongly believe newer advanced INSTI-based regimens containing Dolutegravir are showing promising results in HIV treatment. Dr. Monalisa Sahu Amid this, the City’s renowned Infectious Disease Specialist Dr. Monalisa Sahu said “Dolutegravir belongs to a class of drugs called Integrase strand transfer …
Pharmaceutical company Strides Pharma Science shares rose over 11.5% to hit a 52-week high after the company’s arm received the United States Food and Drug Administration’s tentative approval for a generic HIV treatment drug. Strides Pharma Science Limited’s share price opened at Rs 488 apiece on BSE, and touched an intraday high of Rs 522.20. In its exchange filing, the …
An existing drug used to treat people with HIV has been proven to be effective and safe for younger children, according to research published by Radboud UMC. In 2020, the study extended to children over 20 kilograms, and the latest research provides answers for the care of the smallest children living with HIV; those at least four weeks old and …
